Correction to: Oncogene https://doi.org/10.1038/s41388-019-0953-9, published online 28 August 2019
Following publication of this article, an error was noted in Fig. 1b with the same image being published for BT474 THZ1 and HCC1569 THZ1. After assessing the raw data, the authors confirmed the published image was correct for HCC1569 THZ1, but not BT474 THZ1. The correct image for BT474 THZ1 is provided below.
The authors confirm this correction has no impact on the results and apologise for any inconvenience caused by the error.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sun, B., Mason, S., Wilson, R.C. et al. Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. Oncogene 43, 1972 (2024). https://doi.org/10.1038/s41388-024-02999-1
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41388-024-02999-1
